Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. clinical trial (NCT05421858). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from Fosmanogepix or the other treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. clinical trial (NCT05421858). Contact the study team or your healthcare provider for specific answers.

Question 3

How long will I need to participate in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. clinical trial (NCT05421858). Contact the study team or your healthcare provider for specific answers.

Question 4

What will happen if my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. clinical trial (NCT05421858). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any additional tests or procedures I will need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. clinical trial (NCT05421858). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. clinical trial (NCT05421858). Contact the study team or your healthcare provider for specific answers.

What this study is about